PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
30573812-2	2019	We developed a novel ASBT inhibitor, an N-(3,4-o-dichlorophenyl)-2-(3-trifluoromethoxy) benzamide derivative referred to as IMB17-15, and investigated its therapeutic effects and the molecular mechanisms underlying the effects.	n-(3,4-o-dichlorophenyl)-2-(3-trifluoromethoxy) benzamide	40-97	solute carrier family 10 member 2	Homo sapiens	21-25